Detalhe da pesquisa
1.
[Salivary gland cancer: new therapeutic approaches]. / Cancers des glandes salivaires : nouvelles approches thérapeutiques.
Rev Med Suisse
; 19(827): 958-963, 2023 May 17.
Artigo
em Francês
| MEDLINE | ID: mdl-37195109
2.
[Oncology: what's new in 2022]. / Oncologie : ce qui a changé en 2022.
Rev Med Suisse
; 19(N° 809-10): 52-57, 2023 Jan 18.
Artigo
em Francês
| MEDLINE | ID: mdl-36660838
3.
[2021 Oncology update]. / Oncologie.
Rev Med Suisse
; 18(767): 182-186, 2022 Feb 02.
Artigo
em Francês
| MEDLINE | ID: mdl-35107893
4.
[Anaplastic thyroid carcinoma : new therapeutic approaches]. / Carcinome anaplasique de la thyroïde : nouvelles approches thérapeutiques.
Rev Med Suisse
; 17(739): 962-966, 2021 May 19.
Artigo
em Francês
| MEDLINE | ID: mdl-34009754
5.
[2020 oncology update]. / Oncologie.
Rev Med Suisse
; 17(723): 201-205, 2021 Jan 27.
Artigo
em Francês
| MEDLINE | ID: mdl-33507661
6.
Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanoma.
Cancer Immunol Immunother
; 68(7): 1171-1178, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31172258
7.
Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma.
Int J Mol Sci
; 20(21)2019 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31671550
8.
Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease.
Cancers (Basel)
; 14(12)2022 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35740579
9.
Adjuvant systemic treatment for high-risk resected non-cutaneous melanomas: What is the evidence?
Crit Rev Oncol Hematol
; 167: 103503, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34656746
10.
So-Called Serous Carcinoma of the Uterine Cervix with BRCA2 Mutation: Case Report and Review of the Literature.
Case Rep Oncol
; 14(3): 1792-1798, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35111011
11.
Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice.
Front Oncol
; 9: 464, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31245288
12.
Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Eur J Cancer
; 121: 123-129, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31574417
13.
High incidence of cetuximab-related infusion reactions in head and neck patients.
ESMO Open
; 3(5): e000346, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30094066
14.
Panitumumab as an effective maintenance treatment in metastatic squamous cell carcinoma of the head and neck.
Oral Oncol
; 112: 104984, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888816